Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in osteosarcoma.
Christopher E. Lietz, Erik T. Newman, Andrew D. Kelly, David Haosen Xiang, Ziying Zhang, Caroline A. Luscko, Santiago A. Lozano‐Calderón, David H. Ebb, Kevin A. Raskin, Gregory Michael Cote, Edwin Choy, G. Petur Nielsen, Benjamin Haibe‐Kains, Martin J. Aryee, Dimitrios Spentzos
This study identifies DNA methylation subtypes in osteosarcoma that predict clinical outcomes and response to chemotherapy.
Communications Biology · Mar 8, 2022Peer-reviewedGenetic & Genomic Medicine